Health Science Lecture Series
The Taubman Institute boosts educational outreach by sponsoring a new Health Science Lecture Series
Cancer stem cell expert Dr. Max Wicha will kick off the program
Ann Arbor – The new Health Science Lecture Series will present as its first speaker, Dr. Max Wicha, a Taubman Institute Senior Scholar and the founding director of the U-M Health System’s Comprehensive Cancer Center. As leader of the team that first discovered cancer stem cells in a human solid tumor, Dr. Wicha is a world-renowned expert in the potential of treating virtually any cancer type by targeting these early tumor cells.
“I’m delighted to help kick off this lecture series,” said Dr. Wicha. “Engaging students and the general public in the exciting advances taking place in medical science today is crucial to our role as an education institution. I hope that by explaining how we go about making remarkable discoveries in our laboratories, we’ll inspire more people to choose a career in medical science or join in supporting life-saving research.”
Date: Feb. 20, 2013
Time: 5:30 – 6:30 p.m.
Topic: “Cancer Stem Cells: A New Frontier in Cancer Research”
Location: D. Dan & Betty Kahn Auditorium of the A. Alfred Taubman Biomedical Science Research Building - Click here for a map and directions
Admission: The program is free and open to the public.
The Health Science Lecture Series is sponsored by the Taubman Institute, the Program for Biology and a number of student organizations. The lectures will be held quarterly on the U-M campus and will focus on a wide variety of topics including medical research, public health, bioethics, evolutionary biology, epidemiology and many others.
Help Us Make A Difference. Make A Donation That Could Save Lives.
Taubman Science
ALS patient feels great after stem cell transplant
Took part in Phase I of Dr. Eva Feldman's human clinical trial
Ted Harada tells Crain's Detroit Business that nearly nine months after receiving stem cell injections to his spinal cord, improvement persists.
Click here to read the interview
Clinical Trials
The birth of two human clinical trials
The Taubman Institute’s overriding purpose is to discover potential new treatments that can be tested in clinical trials. Watch as two Taubman Scholars explain how they made it happen.
Taubman Science
Institute training video helps physicians overseas
U-M exam method for diabetic nerve damage translated to Mandarin Chinese. The Taubman Institute has produced video of an exam protocol that will help doctors in Asia and elsewhere as they grapple with growing diabetes epidemics and the resulting complications.
news & events
The Latest
-
Dr. Eva Feldman discusses stem cell therapies on Michigan Radio
June 14, 2013 -
2013 Taubman Prize
June 05, 2013 -
Stem cell treatment "dramatically slows ALS" in some patients
May 31, 2013
Taubman Science
Taubman Scholars direct 31 human clinical trials
Science funded by the Taubman Institute has led to 31 current human clinical trials, studying potential therapies for diseases including breast cancer, muscular dystrophy, diabetes and ALS. See the complete list of trials.
People who care
Generous donors fund institute's summer students
Leadership advisory board members fund Tauber Family Student Internship Program
Three future medical scientists will work with Taubman Institute researchers starting in June.
Accomplishments
State leaders laud Taubman Institute accomplishments
Leaders of state and local government visited the Taubman Institute on March 18 to tour Taubman Scholar labs and discuss the potential medical research offers for both improving the health of residents and establishing new jobs and businesses in Michigan.
Donors pitch in to keep brilliant science minds at U-M Video
